ClinicalTrials.gov
ClinicalTrials.gov Menu

Inflammatory Myopathies in Primary Sjögren's Syndrome (AMISS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03126383
Recruitment Status : Not yet recruiting
First Posted : April 24, 2017
Last Update Posted : April 24, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital, Brest

April 20, 2017
April 24, 2017
April 24, 2017
May 10, 2017
April 10, 2018   (Final data collection date for primary outcome measure)
Proportion of patients fulfilling classification criteria for inflammatory myopathies [ Time Frame: At diagnosis ]
Among the patients included in the AMISS study, we will assess the proportion of patients who fulfill the classification criteria for the different inflammatory myopathies.
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Inflammatory Myopathies in Primary Sjögren's Syndrome
Characterization of Inflammatory Muscle Involvement in Patients With Primary Sjögren's Syndrome
The AMISS study will characterize the features of muscle disease in patients with primary Sjogren's syndrome (pSS).
Muscle disease is associated with pSS, but this association is not well defined. The AMISS study, a retrospective observational multicentric study, will recruit patients with pSS and muscle involvement in order to characterize in details the features of this association (epidemiological aspects, clinical presentation, biological, radiological and histological findings, treatments and outcomes).
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Primary Sjögren's syndrome
Primary Sjögren Syndrome
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
30
Same as current
April 10, 2018
April 10, 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • diagnosis of Primary Sjögren's syndrome according to the ACR/EULAR classification criteria
  • inflammatory muscle involvement, as diagnosed by the treating physician

Exclusion Criteria:

  • Diagnosis of inflammatory myopathy before the diagnosis of pSS
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact: Divi CORNEC 02-98-34-72-64 divi.cornec@chu-brest.fr
France
 
 
NCT03126383
AMISS (29BRC17.0031)
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Not Provided
University Hospital, Brest
University Hospital, Brest
Not Provided
Not Provided
University Hospital, Brest
April 2017